Company: TYRA
Filing Date: 2025-04-18
Form Type: DEF 14A
Source: 0001193125-25-085709
Chunk: 35

Company: Tyra Biosciences, Inc.
Filing Date: 2025-04-18
Form: DEF 14A
Chunk 35
---
 in the applicable year. |

| (3) | For 2023 and 2024, includes a $75 monthly telephone allowance for each named executive officer and life insurance premiums paid by our company for the benefit of each named executive officer for the applicable fiscal year. |

| (4) | Dr. Warner was appointed Chief Medical Officer effective September 9, 2024. The salary and performance bonus amounts for 2024 are pro-rated to reflect Dr. Warner’s partial year of service. |

Narrative to Summary Compensation Table Annual Base Salary The compensation of our named executive officers is generally determined and approved by the Compensation Committee of our Board. The base salary payable to each NEO is intended to provide a fixed component of compensation reflecting the executive’s skill set, experience, role, and responsibilities. Base salaries for our NEOs have generally been set at levels deemed necessary to attract and retain individuals with superior talent. 22

In February 2024, the Compensation Committee approved increases to each of Dr. Harris and Mr. Bensen’s base salary rate for 2024, as shown in the table below, with increases retroactive to January 1, 2024. Dr. Warner was appointed Chief Medical Officer effective September 9, 2024 at the 2024 base salary rate reflected in the table below.

| Named Executive Officer |     | 2023 Base   
 Salary Rate |         |     | 2024 Base   
 Salary Rate |         |     | Percentage 
 Increase   |     |   |
|:------------------------|:----|:------------|--------:|:----|:------------|--------:|:----|:-----------|----:|:--|
| Dr. Harris              |     | $           | 608,400 |     | $           | 632,700 |     |            | 4.0 | % |
| Dr. Warner              |     |             |       — |     | $           | 530,000 |     |            |   — |   |
| Daniel Bensen           |     | $           | 457,600 |     | $           | 475,900 |     |            | 4.0 | % |

We expect that base salaries for our NEOs will be reviewed periodically by our Compensation Committee, with adjustments expected to be made generally in accordance with the considerations described above and to maintain base salaries at competitive levels. Performance Bonus Opportunity In addition to base salaries, in 2024, our named executive officers were eligible to receive